[HTML][HTML] Designing spatial and temporal control of vaccine responses

GA Roth, VCTM Picece, BS Ou, W Luo… - Nature Reviews …, 2022 - nature.com
Vaccines are the key technology to combat existing and emerging infectious diseases.
However, increasing the potency, quality and durability of the vaccine response remains a …

[HTML][HTML] Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19

R Alon, M Sportiello, S Kozlovski, A Kumar… - Nature Reviews …, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019 (COVID-19). Understanding of the fundamental processes …

[HTML][HTML] Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score

L Guo, D Wei, X Zhang, Y Wu, Q Li, M Zhou… - Frontiers in …, 2019 - frontiersin.org
Objective The aim of this study was to further clarify clinical characteristics and predict
mortality risk among patients with viral pneumonia. Methods A total of 528 patients with viral …

[HTML][HTML] Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

M Koutsakos, PT Illing, THO Nguyen, NA Mifsud… - Nature …, 2019 - nature.com
Abstract Influenza A, B and C viruses (IAV, IBV and ICV, respectively) circulate globally and
infect humans, with IAV and IBV causing the most severe disease. CD8+ T cells confer cross …

[HTML][HTML] Advances in development and application of influenza vaccines

J Chen, J Wang, J Zhang, H Ly - Frontiers in immunology, 2021 - frontiersin.org
Influenza A virus is one of the most important zoonotic pathogens that can cause severe
symptoms and has the potential to cause high number of deaths and great economic loss …

Dynamic balance of pro‐and anti‐inflammatory signals controls disease and limits pathology

JM Cicchese, S Evans, C Hult, LR Joslyn… - Immunological …, 2018 - Wiley Online Library
Immune responses to pathogens are complex and not well understood in many diseases,
and this is especially true for infections by persistent pathogens. One mechanism that allows …

Is a universal influenza virus vaccine possible?

R Nachbagauer, P Palese - Annual review of medicine, 2020 - annualreviews.org
Influenza viruses remain a severe burden to human health because of their contribution to
overall morbidity and mortality. Current seasonal influenza virus vaccines do not provide …

[HTML][HTML] Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature

A Hensel, R Bauer, M Heinrich, V Spiegler… - Planta …, 2020 - thieme-connect.com
As viral infections are an increasing threat to human societies, the need for new therapeutic
strategies is becoming even more obvious. As no vaccine is available for COVID-19, the …

[HTML][HTML] Immune control of avian influenza virus infection and its vaccine development

P Dey, A Ahuja, J Panwar, P Choudhary, S Rani… - Vaccines, 2023 - mdpi.com
The avian influenza A virus (AIV) is naturally prevalent in aquatic birds, infecting different
avian species and transmitting from birds to humans. Both AIVs, the H5N1 and H7N9 …

[HTML][HTML] Downregulation of MHC class I expression by influenza A and B viruses

M Koutsakos, HEG McWilliam, TE Aktepe… - Frontiers in …, 2019 - frontiersin.org
Manipulation of the MHC-I presentation pathway, and thus limiting MHC-I cell surface
expression, is used by many viruses to evade immune recognition. In particular …